Copyright 2011  -   BioMosaics Inc. 655 Spear St. Building C, Burlington, VT 05405  -  +1 877 742-2066

 

MCJ Protein (DnaJ C 15) mAb Clone 3C1  Biomarker for drug resistance in breast and ovarian cancer.

 

Hatle et al., 2007 Mol. Cell Biol. 27 (8): 2952-66        Catalog #s B0027R; B0527R

Welcome to BioMosaics

BioMosaics is a biomarker development company.  We commercialize biomarker assays and reagents for the early detection of cancer, for use in clinical and research settings.  In addition to our antibody products for clinical immunohistochemistry, we are developing novel oncology immunoassays for circulating tumor markers, as well as assays for detection of DNA damage and somatic mutation.